Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1158/2159-8290.CD-20-0559 http://scihub22266oqcxt.onion/10.1158/2159-8290.CD-20-0559 32444466!7357668!32444466     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Cancer+Discov 2020 ; 10 (7): 916-921 Nephropedia Template TP {{tp|p=32444466|t=2020. The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2 |pdf=|usr=}}{{32444466}} gab.com Text The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2 JO: Cancer Discov http://www.kidney.de/pget.php?&tw=1&pmid=32444466 #FOAvip The mapping of SARS-CoV-2 human protein-protein interactions by Gordon and colleagues revealed druggable targets that are hijacked by the virus. Here, we highlight several oncogenic pathways identified at the host-virus interface of SARS-CoV-2 to enable cancer biologists to apply their knowledge for rapid drug repurposing to treat COVID-19, and help inform the response to potential long-term complications of the disease. Twit Text FOAVip The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2 ????Cancer Discov http://www.kidney.de/pget.php?&tw=1&pmid=32444466 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32444466 #FOAvip English Wikipedia <ref>{{Cite pmid|32444466}}</ref> The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2 #MMPMID32444466 Tutuncuoglu B; Cakir M; Batra J; Bouhaddou M; Eckhardt M; Gordon DE; Krogan NJ Cancer Discov 2020[Jul]; 10 (7): 916-921 PMID32444466show ga The mapping of SARS-CoV-2 human protein-protein interactions by Gordon and colleagues revealed druggable targets that are hijacked by the virus. Here, we highlight several oncogenic pathways identified at the host-virus interface of SARS-CoV-2 to enable cancer biologists to apply their knowledge for rapid drug repurposing to treat COVID-19, and help inform the response to potential long-term complications of the disease. |*Betacoronavirus[MESH] |*Drug Repositioning[MESH] |COVID-19[MESH] |Cell Cycle[MESH] |Coronavirus Infections/*drug therapy/genetics/metabolism/physiopathology[MESH] |DNA Damage[MESH] |Epigenomics[MESH] |Humans[MESH] |Neoplasm Proteins/*antagonists & inhibitors/drug effects[MESH] |Neoplasms/*drug therapy/genetics/metabolism/physiopathology[MESH] |Pandemics[MESH] |Pneumonia, Viral/*drug therapy/genetics/metabolism/physiopathology[MESH] |Protein Biosynthesis[MESH]The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2 (epmc).pdf DeepDyve Pubget Overpricing